Researchers have found that a single measurement of GCD59, a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes. It was also associated with the probability of delivering a large-for-gestational-age newborn.